By disparaging public-health methods and discrediting vaccines, the COVID‑19 minimizers cost hundreds of thousands of people ...

The World Health Organization wants to tackle inequity and bureaucracy relating to clinical trials. Will its latest guidance make a difference? Anna Volkmer reports During the covid-19 pandemic the UK ...

Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine demand and pipeline ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

A former NYU housing manager is suing the university for religious-based discrimination, claiming he was wrongfully ...

NIH grant recipients receive additional funding to cover "indirect costs," such as building maintenance and administrative ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...

In a new book, pediatric infectious disease specialist Dr. Adam Ratner details the history of measles, a virus that’s often a ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

The tech billionaires who attended the inauguration of President Donald J. Trump are not the oligarchs seen in Russia or ...